US-guided Intralesional Injection of Cystic Hygroma - A Case Report
NCT ID: NCT07246928
Last Updated: 2025-11-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
1 participants
INTERVENTIONAL
2024-09-01
2025-10-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Bilateral Sacroiliac Joint (SIJ) Injection in Lumbar Disc Prolapse
NCT04326699
Ultra-sounded Guided Regional Blockade for Lipoma Excision
NCT02753361
Bladder Distension for Pain Relief in Patients With Excessive Anteflexion of Uterus Undergoing Office Hysteroscopy
NCT06642311
Cavity Evaluation Before Intracytoplasmic Sperm Injection
NCT04257708
Sclerotherapy and Bone Marrow Injection In Aneurysmal Bone Cyst
NCT05696834
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
pediatric patient
Intralesional Injection of Bleomycin
Aspiration of Cystic Hygroma Fluid and Intralesional Injection
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intralesional Injection of Bleomycin
Aspiration of Cystic Hygroma Fluid and Intralesional Injection
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
1 Month
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Delta University for Science and Technology
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sarah Arafat
Lecturer of Oral and Maxillofacial Surgery, Faculty of Oral and Dental Medicine, Delta University for Science & Technology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gamal El-Tagy, MD
Role: STUDY_DIRECTOR
pediatric surgery department, Cairo University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Specialized Pediatric Hospital (Abu EL-Reesh Japanese hospital)
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
025091866
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.